Concurrent administration of rituximab and CHOP chemotherapeutic agents for outpatients with CD20-positive lymphoma.
Yakushijin Y, Tatsukawa T, Yamaguchi T, Egawa T, Hidaka N, Ido K, Suemaru K, Yasukawa M, Araki H.
Yakushijin Y, et al. Among authors: yasukawa m.
Anticancer Agents Med Chem. 2012 Sep;12(7):829-34. doi: 10.2174/187152012802650138.
Anticancer Agents Med Chem. 2012.
PMID: 22721383
Clinical Trial.
R (rituximab)-CHOP (cyclophosphamide, adriamycin, vincristin, and prednisone) is given to outpatients with CD20-positive lymphoma as a standard treatment. However, this regimen requires long-term infusion because of the necessity for monitoring the infusion reaction (IR) d …
R (rituximab)-CHOP (cyclophosphamide, adriamycin, vincristin, and prednisone) is given to outpatients with CD20-positive lymphoma as a stand …